GSK Stock Analysis: Attractive Price For Incredible Dividend Yield


  • GlaxoSmithKline’s stock price has fallen over the past year as its core performance struggles.gsk stock analysis
  • The price is now near its 52-week low, and is unlikely to fall much further limiting the risk involved with the stock.
  • Sales will improve next year, offering upside potential, and investors can enjoy the dividend yield until then.
  • I Know First Algorithm is bullish on this stock for the long-term, believing it is perfect for patient, income-seeking investors.
I Know First has a bullish algorithmic forecast for this stock along with the bullish fundamental analysis.

Read The Full Seeking Alpha Article